Evidence map›Paper›PMID 38932156›Full record

ArticleViruses2024

Detection of Equine Parvovirus-Hepatitis Virus and Equine Hepacivirus in Archived Sera from Horses in France and Australia.

Christine Fortier, Charles El-Hage, Camille Normand, Erika S Hue, Gabrielle Sutton, Christel Marcillaud-Pitel, Kim Jeffers, Nicholas Bamford, Elise Oden, Romain Paillot and 3 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christine FortierLABÉO, 14280 Saint-Contest, France.
Charles El-HageCentre for Equine Infectious Diseases, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC 3010, Australia.ORCID 0000-0002-6999-2664
Camille NormandLABÉO, 14280 Saint-Contest, France.ORCID 0000-0002-8920-1911
Erika S HueLABÉO, 14280 Saint-Contest, France.ORCID 0000-0001-6930-3606
Gabrielle SuttonLABÉO, 14280 Saint-Contest, France.
Christel Marcillaud-PitelRESPE (Réseau d'Epidémio-Surveillance en Pathologie Équine), 14280 Saint-Contest, France.
Kim JeffersCentre for Equine Infectious Diseases, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC 3010, Australia.
Nicholas BamfordCentre for Equine Infectious Diseases, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC 3010, Australia.ORCID 0000-0001-7675-9126
Elise OdenLABÉO, 14280 Saint-Contest, France.
Romain PaillotLABÉO, 14280 Saint-Contest, France.ORCID 0000-0003-3081-2037
Carol HartleyCentre for Equine Infectious Diseases, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC 3010, Australia.
James GilkersonCentre for Equine Infectious Diseases, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC 3010, Australia.
Stéphane PronostLABÉO, 14280 Saint-Contest, France.ORCID 0000-0002-2584-0933

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reports of newly discovered equine hepatotropic flavi- and parvoviruses have emerged throughout the last decade in many countries, the discovery of which has stimulated a great deal of interest and clinical research. Although commonly detected in horses without signs of disease, equine parvovirus hepatitis (EqPV-H) and equine hepacivirus (EqHV) have been associated with liver disease, including following the administration of contaminated anti-toxin. Our aim was to determine whether EqPV-H and EqHV are present in Australian horses and whether EqPV-H was present in French horses and to examine sequence diversity between strains of both viruses amongst infected horses on either side of the globe. Sera from 188 Australian horses and 256 French horses from horses with and without clinical signs of disease were collected. Twelve out of 256 (4.7%) and 6 out of 188 (3.2%) French and Australian horses, respectively, were positive for the molecular detection of EqPV-H. Five out of 256 (1.9%) and 21 out of 188 (11.2%) French and Australian horses, respectively, were positive for the molecular detection of EqHV. Australian strains for both viruses were genomically clustered, in contrast to strains from French horses, which were more broadly distributed. The findings of this preliminary survey, with the molecular detection of EqHV and EqPV-H in Australia and the latter in France, adds to the growing body of awareness regarding these recently discovered hepatotropic viruses. It has provided valuable information not just in terms of geographic endemicity but will guide equine clinicians, carers, and authorities regarding infectious agents and potential impacts of allogenic tissue contamination. Although we have filled many gaps in the world map regarding equine hepatotropic viruses, further prospective studies in this emerging field may be useful in terms of elucidating risk factors and pathogenesis of these pathogens and management of cases in terms of prevention and diagnosis.

Indexed as

HepacivirusHepatitis, Viral, AnimalHorse DiseasesParvoviridae InfectionsParvovirusPhylogenyAnimalsAustraliaFranceHepatitis CHorsesAustraliaequine hepacivirusequine parvovirus hepatitis virusFrancefrequencyhorsesphylogeny

Identifiers

PMID38932156
PMCPMC11209535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.